Should PARP Inhibitors Have Tumor-Agnostic Approval Status?

Listen to Maurie Markman, MD discuss PARP inhibitors.

Join our community Sign up for updates from Let’s Win!

Let’s Win! Pancreatic Cancer is an online community for sharing information about innovative, science-based treatments for pancreatic cancer. Please note that this information is not intended to be a substitute for professional medical opinion, advice, or diagnosis. We encourage you to use this information to begin a dialogue with your physician about the treatment plan that is right for you.